These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37918703)

  • 1. Links among genetic variants and hierarchical brain structural and functional networks for antidepressant treatment: A multivariate study.
    Sun Y; Hou Y; Wang X; Wang H; Yan R; Xue L; Yao Z; Lu Q
    Brain Res; 2024 Jan; 1822():148661. PubMed ID: 37918703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Investigation into the Association Between Dopamine Receptor D1 Multilocus Genetic Variation, Multiparametric Magnetic Resonance Imaging, and Antidepressant Treatment.
    Sun Y; Wang X; Tian S; Chen Z; Wang H; Xue L; Yan R; Yao Z; Lu Q
    J Magn Reson Imaging; 2022 Jul; 56(1):282-290. PubMed ID: 34870351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rehabilitative compensatory mechanism of hierarchical subnetworks in major depressive disorder: A longitudinal study across multi-sites.
    Wang X; Qin J; Zhu J; Bi K; Zhang S; Yan R; Zhao P; Yao Z; Lu Q
    Eur Psychiatry; 2019 May; 58():54-62. PubMed ID: 30822739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function coupling and hierarchy-specific antidepressant response in major depressive disorder.
    Wang X; Xue L; Hua L; Shao J; Yan R; Yao Z; Lu Q
    Psychol Med; 2024 Jul; 54(10):2688-2697. PubMed ID: 38571298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural alterations of the brain preceded functional alterations in major depressive disorder patients: Evidence from multimodal connectivity.
    Yao Z; Zou Y; Zheng W; Zhang Z; Li Y; Yu Y; Zhang Z; Fu Y; Shi J; Zhang W; Wu X; Hu B
    J Affect Disord; 2019 Jun; 253():107-117. PubMed ID: 31035211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconfiguration of hub-level community structure in depressions: A follow-up study via diffusion tensor imaging.
    Qin J; Liu H; Wei M; Zhao K; Chen J; Zhu J; Shen X; Yan R; Yao Z; Lu Q
    J Affect Disord; 2017 Jan; 207():305-312. PubMed ID: 27741467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Creatine Monohydrate Augmentation on Brain Metabolic and Network Outcome Measures in Women With Major Depressive Disorder.
    Yoon S; Kim JE; Hwang J; Kim TS; Kang HJ; Namgung E; Ban S; Oh S; Yang J; Renshaw PF; Lyoo IK
    Biol Psychiatry; 2016 Sep; 80(6):439-447. PubMed ID: 26822799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupted rich-club network organization and individualized identification of patients with major depressive disorder.
    Liu X; He C; Fan D; Zhu Y; Zang F; Wang Q; Zhang H; Zhang Z; Zhang H; Xie C
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110074. PubMed ID: 32818534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of early improvement of major depressive disorder to antidepressant medication in adolescents with radiomics analysis after ComBat harmonization based on multiscale structural MRI.
    Ma H; Zhang D; Wang Y; Ding Y; Yang J; Li K
    BMC Psychiatry; 2023 Jun; 23(1):466. PubMed ID: 37365541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rich-club reorganization and related network disruptions are associated with the symptoms and severity in classic trigeminal neuralgia patients.
    Zhang P; Wan X; Ai K; Zheng W; Liu G; Wang J; Huang W; Fan F; Yao Z; Zhang J
    Neuroimage Clin; 2022; 36():103160. PubMed ID: 36037660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm avoidance involved in mediating the association between nerve growth factor (NGF) gene polymorphisms and antidepressant efficacy in patients with major depressive disorder.
    Yeh YW; Kuo SC; Chen CY; Liang CS; Ho PS; Yen CH; Chen TY; Shyu JF; Wan FJ; Lu RB; Huang SY
    J Affect Disord; 2015 Sep; 183():187-94. PubMed ID: 26021968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Volume-Related Polymorphisms of the Glycogen Synthase Kinase-3β Gene and Their Effect on Antidepressant Treatment in Major Depressive Disorder.
    Sunada N; Takekita Y; Nonen S; Wakeno M; Koshikawa Y; Ogata H; Kinoshita T; Kato M
    Neuropsychobiology; 2019; 78(3):136-144. PubMed ID: 31189175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity.
    Mocking RJT; Nap TS; Westerink AM; Assies J; Vaz FM; Koeter MWJ; Ruhé HG; Schene AH
    Psychoneuroendocrinology; 2017 May; 79():84-92. PubMed ID: 28262603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of antidepressant treatment on long-range and short-range functional connectivity strength in patients with major depressive disorder.
    An J; Wang L; Li K; Zeng Y; Su Y; Jin Z; Yu X; Si T
    Sci Rep; 2017 Aug; 7(1):10214. PubMed ID: 28860564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eight-week antidepressant treatment changes intrinsic functional brain topology in first-episode drug-naïve patients with major depressive disorder.
    Dai YR; Wu YK; Chen X; Zeng YW; Li K; Li JT; Su YA; Zhu LL; Yan CG; Si TM
    J Affect Disord; 2023 May; 329():225-234. PubMed ID: 36858265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.
    Licinio J; Dong C; Wong ML
    Arch Gen Psychiatry; 2009 May; 66(5):488-97. PubMed ID: 19414708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder.
    Fonseka TM; MacQueen GM; Kennedy SH
    J Affect Disord; 2018 Jun; 233():21-35. PubMed ID: 29150145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Neuroimaging Biomarkers for Antidepressant Selection in Early Treatment of Depression.
    Xue L; Pei C; Wang X; Wang H; Tian S; Yao Z; Lu Q
    J Magn Reson Imaging; 2021 Aug; 54(2):551-559. PubMed ID: 33634921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal Investigation of Network Level Effects Using Intrinsic Functional Connectivity, Anatomical Covariance, and Structure-to-Function Correlations in Unmedicated Major Depressive Disorder.
    Scheinost D; Holmes SE; DellaGioia N; Schleifer C; Matuskey D; Abdallah CG; Hampson M; Krystal JH; Anticevic A; Esterlis I
    Neuropsychopharmacology; 2018 Apr; 43(5):1119-1127. PubMed ID: 28944772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.